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Abstract 
Systems of antigen delivery into antigen-presenting cells represent an important novel strategy in chicken vaccine 
development. In this study, we verified the ability of Rous sarcoma virus (RSV) antigens fused with streptavidin to 
be targeted by specific biotinylated monoclonal antibody (anti-CD205) into dendritic cells and induce virus-specific 
protective immunity. The method was tested in four congenic lines of chickens that are either resistant or suscep-
tible to the progressive growth of RSV-induced tumors. Our analyses confirmed that the biot-anti-CD205-SA-FITC 
complex was internalized by chicken splenocytes. In the cytokine expression profile, several significant differences 
were evident between RSV-challenged progressor and regressor chicken lines. A significant up-regulation of IL-2, 
IL-12, IL-15, and IL-18 expression was detected in immunized chickens of both regressor and progressor groups. Of 
these cytokines, IL-2 and IL-12 were most up-regulated 14 days post-challenge (dpc), while IL-15 and IL-18 were most 
up-regulated at 28 dpc. On the contrary, IL-10 expression was significantly down-regulated in all immunized groups 
of progressor chickens at 14 dpc. We detected significant up-regulation of IL-17 in the group of immunized progres-
sors. LITAF down-regulation with iNOS up-regulation was especially observed in the progressor group of immunized 
chickens that developed large tumors. Based on the increased expression of cytokines specific for activated dendritic 
cells, we conclude that our system is able to induce partial stimulation of specific cell types involved in cell-mediated 
immunity.
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provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Introduction
Generation of de novo adaptive responses, including 
responses to vaccines, is primarily elicited by dendritic 
cells (DC), specialized leukocytes adapted for antigen 
capture, processing and presentation to T lymphocytes. 
Knowledge of these cells in a target species is therefore 
crucial in finding the most effective means of vaccina-
tion. The key role of T cell-mediated responses to cancer 
has been established in several models [1]. The antitu-
mor immune response relies on DC, which act as pro-
fessional antigen-presenting cells (APC). Altered DC 
function is common in tumors producing soluble fac-
tors—cytokines—with immunosuppressive activity [2, 
3]. DC express, among other, the CD205 (Ly75, DEC205) 
molecule that functions as an endocytic receptor involved 
in the uptake of extracellular antigens. In the chicken, the 
presence of this molecule was also confirmed, along with 
its endocytic properties [4]. Importantly, DC could be 
targeted with antigen-conjugated monoclonal antibodies 
specific for CD205, which are then efficiently internal-
ized, processed in the endosomal compartment, and pre-
sented to both major histocompatibility complex I (MHC 
I) and MHC II molecules [5].
In this study, we used a monoclonal antibody (anti-
CD205) for direct antigen delivery. This strategy of 
activating different DC populations by direct in vivo tar-
geting of their surface receptors has been pioneered by 
Steinman and Nussenzweig, who used antigen coupling 
to antibodies to target receptors on DC surfaces [6–8]. 
We used genetic fusion of the antigen with streptavidin 
(SA), which in its tetrameric form binds a biotinylated 
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antibody targeting a surface receptor on the APC. Thus 
prepared complexes can deliver immunogens into DC 
through endocytosis with the selected surface receptor, 
enabling antigen processing and presentation, and lead-
ing to induction of adaptive immunity [9, 10].
We applied this novel vaccination approach to our pre-
viously described model system of inbred lines resistant 
(CB, CB.RI; regressors) or susceptible (CC, CC.RI; pro-
gressors) to progressive growth of Rous sarcoma virus 
(RSV)-induced tumors [2, 3]. RSV harbors the onco-
gene v-src, which is responsible for cell transformation 
[11]. Previous studies using the model system of Prague 
congenic lines established a decisive role of the B-F—
chicken MHC class I—genes in the ability to regress 
RSV-induced tumors [12]. The immune-based mecha-
nism of tumor regression in this experimental system has 
also been demonstrated. Both v-src and RSV envelope 
(env) proteins serve as antigens in particular chicken 
lines [13–16]. On the contrary to the MHC of typical 
mammals, there is only a single dominantly expressed 
class I molecule in the chicken MHC, which is of crucial 
importance for the function of particular haplotypes [17, 
18]. Dominantly expressed class I (B-F) molecules of the 
B-F12 and B-F4 haplotypes of congenic lines CB and CC, 
respectively, have been analyzed in detail as to the bind-
ing capacity of predicted peptides derived either from 
the v-src oncogene or env-encoded protein products 
of RSV [19–21]. Furthermore, coevolution of the B-F 
and peptide transporter genes (TAP) within the above-
mentioned haplotypes has been established [20]. Thus, 
the ability of certain class I (B-F) molecules to specifi-
cally bind the RSV-derived peptides correlates precisely 
with the outcome of the RSV-induced tumors—regres-
sion/progression [19, 22]. The molecular mechanism 
of B-F (class I) and TAP interaction is well understood 
[20]. On the contrary, the function of the B-G (class IV) 
molecules and their possible interaction with the B-F 
(class I) molecules is still not clear [23], despite a wealth 
of experimental evidence suggesting the role of the B-G 
molecules in modulation of some immune based phe-
nomena [24–28].
In this study, we describe a new system of antigen 
delivery into chicken DC and assess its potential for vac-
cination of chickens. In order to get some insight into the 
cellular and molecular mechanisms, we paid particular 
attention to changes in the cytokine profile after vaccina-
tion and immune challenge.
Materials and methods
For preparation of anti-chCD205 and for construction, 
expression and purification of the recombinant SA-RSV 
fusion proteins, see Additional files 1, 2, 3.
Experimental animals
All immunization and tumor induction experiments were 
carried out with the highly inbred chicken lines CB (B12/
B12), CB.RI (B12r1/B12r1) and CC (B4/B4), CC.RI (B4r1/
B4r1) maintained at the Institute of Molecular Genet-
ics, Prague. Recombinant haplotype B12r1 is composed 
of B-F12 and B-G4 genes whereas the haplotype B4r1 is 
reciprocal being composed of B-F4 and B-G12 genes [29]. 
All chicken lines were free of exogenous avian leukosis 
viruses. All procedures were conducted in accordance 
with the EU Directive 2010/63/EU for animal experi-
ments, comply with the ARRIVE guidelines and with the 
Guide for the Care and Use of Laboratory Animals and 
were approved by the Animal Care and Use Committee 
of the Academy of Sciences of the Czech Republic.
Specificity of the monoclonal antibody anti‑chCD205 
and its internalization
For Western blotting, the recombinant proteins CD205B 
and CD205F were separated on Tris-Tricine SDS PAGE 
and transferred to the nitrocellulose membrane (Immo-
bilon-P, GE Healthcare). Membranes were blocked 
with 5% nonfat milk in PBS containing 0.05% Tween-20 
(PBST) for 1 h at room temperature, incubated with pri-
mary antibodies in PBST containing 5% nonfat milk for 
1 h at room temperature prior to incubation with horse-
radish peroxidase-conjugated goat anti-mouse antibody 
(GE Healthcare) diluted in 5% nonfat milk PBST for 1 h 
at room temperature. Detection was carried out using a 
SuperSignal West Femto Maximum Sensitivity Substrate 
chemiluminescence reagent kit (Pierce, Thermo Fisher 
Scientific).
For the flow cytometry, peripheral blood mononu-
clear cells (PBMC) were isolated from chicken heparin-
ized blood samples. Pieces of freshly isolated chicken 
spleen were crushed on a steel sieve. Splenocytes as well 
as PBMC were washed and centrifuged in a 1.077 den-
sity Histopaque gradient (Sigma-Aldrich) to remove 
nucleated erythrocytes. The monoclonal antibodies 
against chicken antigens CD4 (MCA2164F, AbDSero-
tec, USA), CD8a (MCA2166PE, AbDSerotec, USA), 
Bu1 (8395-08, AV20, Southern Biotech, USA), MHCII 
(8350-01, 2G11, Southern Biotech, USA), KUL01 (8420-
02, Southern Biotech, USA), TCRλδ (CON5-CZ, TCR1, 
Exbio, Czech Republic), and putative CD11c (clone 8F2, 
a generous gift from Prof. Kaspers, University of Munich) 
were used. Conjugated complexes CD205-biot (clone 
104-2C4/D8) and SA-FITC (SA1001, Invitrogen, USA) 
as well as secondary antibodies rabbit anti-mouse IgG-
APC (SAB1426, Gentaur), mouse anti-chicken IgG-FITC 
(clone G-1, Southern Biotech, USA), and goat anti-mouse 
IgM-PE (sc-3768, SantaCruz Biotech) were employed.
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For internalization, chicken spleen cells were incubated 
at 1 × 106 cells per well at 4  °C with 1.5 µg/mL of anti-
body against CD205-biot. The cells were then washed 
and incubated with SA-FITC conjugate for 1  h at 4  °C. 
After that, the cells were incubated either at 40 or 4  °C 
for 1 or 2 h. The reduction of mean fluorescence inten-
sity (MFI) of the cell surface-bound anti-chCD205 mon-
oclonal antibody after endocytosis was calculated as 
100 −  ((MFI biot-mAb + FITC-SA 40  °C) −  (MFI biot-
control Ig + FITC-SA 4 °C)/(MFI biot-mAb + FITC-SA 
4  °C) −  (MFI biot-control Ig +  FITC-SA 4  °C)) ×  100. 
The cells were analyzed using a FacsCalibur device (Bec-
ton–Dickinson) and FlowJo software (TreeStar).
Immunization of chickens
Chickens were immunized with a dose of 100 nmol of the 
mixture of SA-RSV tetramers complexed with 200 nmol 
anti-CD205 in the presence of 200  µg poly I:C (Sigma 
Aldrich, P1530) per chicken. The mixture of SA-RSV 
was composed of equal amounts of tetramers SA-vsrcA; 
SA-vsrcB; SA-ENVoep; SA-ENVly; SA-POL; SA-GAG—
approximately 17 nmol (~4 µg) of each per chicken. The 
immunization dose was adjusted as described previously 
[9, 10]. The control group was mock-immunized with 
200 µg of poly I:C per chicken.
Chickens were immunized with 0.2 mL of appropriately 
diluted freshly prepared antigenic solution subcutane-
ously (sc) into the left wing web (needle 23G × 25 mm). 
Immunization was repeated three times, first at the age 
of three weeks and then with two consecutive boosts at 
7-day intervals.
RSV challenge, tumor monitoring
The Prague strain of RSV (PR-RSV-C) was used [30] as 
tumor inducing challenge. Chickens were sc inoculated 
with a dose of to 100 (CB, CB.RI) or 20 (CC, CC.RI) 
focus-forming units (FFU) in 0.2  mL of cultivation 
medium (DMEM) into the outer area of pectoral muscle 
one week after the last immunization. At the end of the 
defined experimental period (28–35 days post-challenge, 
dpc), chickens were sacrificed, tumors were excised and 
weighed with 0.1  g precision. Tumors were then arbi-
trarily divided into two groups: small tumors, i.e. tumors 
up to 5 g (including completely regressed tumors) in the 
regressor lines CB and CB.RI, and tumors up to 20 g in 
the progressor lines CC and CC.RI; large tumors, i.e. 
tumors over 5 g in the CB and CB.RI, and over 20 g in the 
CC and CC.RI lines.
RNA isolation, reverse transcription
Leukocytes from whole blood were obtained using His-
topaque-1077 (Sigma) centrifugation. Total RNA from 
chicken leukocytes was isolated using Tri Reagent 
according to the manufacturer’s protocol (MRC, USA; 
Thermo Scientific, USA). RNA integrity number (RIN) 
was measured using capillary electrophoresis performed 
in Agilent Bioanalyzer 2100 with RNA 6000 Nano Assay 
(Agilent Technologies, CA, USA) and was adjusted to be 
higher than 6.5 in all samples selected for the analyses. 
RNA samples (400  ng/µL) were reverse transcribed to 
cDNA using a Transcriptor High Fidelity cDNA Synthesis 
Kit (Roche) according to the manufacturer’s instructions.
Gene expression analysis
Gene expression analysis was performed in BioMark 
(Fluidigm, CA, USA), which enables a large number of 
real-time PCR (RT-PCR) reactions in a single run. Before 
BioMark analysis, the samples were pre-amplified. The 
RT-PCR reactions were carried out in GE Dynamic Chip 
96.96 in a BioMark HD System (Fluidigm). 5 µL of sample 
premix consisted of 1  µL of 20 ×  diluted pre-amplified 
cDNA, 0.25 µL of 20 × DNA Binding Dye Sample Load-
ing Reagent (Fluidigm), 2.5 µL of FastEvaGreen Supermix 
(Bio-Rad), 0.1 µL of 4 × diluted ROX (Invitrogen, USA) 
and 1.15 µL of RNase/DNase-free water. Each 5 µL assay 
premix consisted of 2.5 µL of 10 µM primers and 2.5 µL 
of DA Assay Loading Reagent (Fluidigm). The conditions 
of RT-PCR were the following: 95 °C for 3 min, 30 cycles 
of 95  °C for 5  s, and 60  °C for 20  s. The melting curve 
analysis was then performed. Primers were designed 
using Primer3 software or described sequences were 
used [31, 32] (Additional file  4). The GAPDH and 28S 
reference genes were selected out of the reference gene 
candidates by Normfinder (GenEx, Sweden). Each sam-
ple was analyzed in three technical replicates. The data 
were collected using BioMark 3.1.2. Data Collection soft-
ware and analyzed by Fluidigm Real-Time PCR Analysis 
Software 4.1.2. (Fluidigm).
The cut-off value for Cq was set at 23 and values higher 
than that were replaced by the Cq value of 25. A few 
missing values were replaced by the highest value plus 
2, then the data were recalculated into relative quanti-
ties and logarithms were applied. Data were normalized 
with GAPDH. The fold change in expression was calcu-
lated using the 2-Cq method for each sample and then 
expressed as the mean of all fold changes. The control 
was set as 100% and experimental samples were com-
pared to the control.
In vitro antigen restimulation and Multiplex cytokine 
assays
Chickens were sc immunized three times at seven day 
intervals with a dose of 100 nmol of the SA-RSV tetram-
ers (equal amounts of tetramers SA-vsrcA; SA-vsrcB; 
50 nmol of each) complexed with 200 nmol biotin-anti-
CD205 in the presence of 200  µg poly I:C per chicken. 
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At day 10 after the last immunization, PBMC were iso-
lated and in  vitro restimulated (250  000 cells/well) with 
SA-vsrcA  +  SA-vsrcB antigen (10  μg/ mL) and free SA 
(10  μg/ mL) as a control. Cells were cultivated at 37  °C 
in RPMI-1640 (Sigma) supplemented with 10% FBS 
(Gibco) and 1% Glutamine–Penicillin–Streptomycin 
(Sigma). 4  days after in  vitro restimulation, the v-src-
specific interleukin (IL-12, IL-2, IFNγ, IL-10) responses 
were measured using the Bio-Plex system in the cul-
ture supernatants. For each cytokine, the recombinant 
protein, capture antibody and detection antibody were 
obtained as complete kit (Kingfisher Biotech, USA; 
cat.nos. DIY0686C-003 IL-12; DIY0685C-003 IL-2; 
DIY0684C-003 IFNγ; DIY1118C-003 IL-10).
Culture supernatants from Ag-restimulation assays 
were collected at the indicated time. Cytokine profiles 
were then tested using Bio-Plex Pro Assays (BIO-RAD) 
according to the manufacturer’s instructions. Each 
cytokine was tested in a single bead assay to determine 
the optimal concentration of antibody detection. The 
microspheres were multiplexed and optimized for incu-
bation times and Streptavidin-PE reporter signal. All 
assays were performed with the same matrix as the cul-
ture supernatants, calibration curves from recombinant 
cytokine standards were prepared with threefold dilution 
steps. Measurements and data analysis of all assays were 
performed with the Bio-Plex system in combination with 
the Bio-Plex Manager Software.
Statistical analyses
The weights of individual tumors were compared using 
ANOVA with Fisher LSD test, Mann–Whitney test and 
t test. Data of gene expression were prepared in Genex 
5.3.7 software (GenEx). The following analysis was done 
in SAS 9.4 software. Groups were compared by repeated 
three-way ANOVA. Contrasts were used for detailed 
comparison. Linear discriminant function analysis based 
on all analyzed genes was used to show separation of dif-
ferent groups. The cytokine expression profiles of RSV-
challenged chicken groups were classified using methods 
of principal component analysis (PCA) [33] and linear 




The complete sequence of the RSV antigens v-src, env, 
pol and gag were fused to the N- and C-terminus of the 
tetramerization core of streptavidin. The SA fusion with 
whole antigens v-src and env did not form stable tetram-
ers due to their size. These two antigens were therefore 
split into two overlapping parts. In env, the signal, trans-
membrane and intracellular domain were also excluded 
(Figure 1A). All fusion proteins were produced in E. coli 
and purified close to homogeneity (Figure 1B). The fusion 
proteins with antigens fused to the C- terminal part of SA 
(SA-RSV) were isolated in higher purity and displayed 
longer stability than the N-terminus fusions (RSV-SA). 
The SA-RSV tetramers were therefore used for the vac-
cination study.
Specificity and internalization capacity of the monoclonal 
antibody anti‑chCD205
The specificity of newly prepared anti-chCD205 
monoclonal antibodies was tested by ELISA against 
Figure 1 Expression and purification of Ag-SA fusion proteins. 
A Amino acid sequence of SA-RSV fusion protein. B Purified SA-RSV 
fusion protein (15 µg) eluted from the 2-Iminobiotin Agarose column 
was separated in Tris-Tricine SDS-PAGE gel and the proteins were 
visualized by Coomassie blue staining. 1—SA-V-srcA; 2—SA-V-srcB; 
3—SA-ENVoep; 4—SA-ENVly; 5—SA-GAG; 6—SA-POL. All samples 
were heated to 100 °C for tetramer dissociation. Only the denatured 
monomeric forms of antigen streptavidin fusion proteins are visual-
ized on the gel.
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recombinant antigens CD205B and CD205F (data not 
shown). The specificity of the positive clones was veri-
fied on Western blot, where the recombinant proteins 
CD205B and CD205F were detected using different 
clones of monoclonal antibodies (Figure 2A). For the pur-
pose of antigen delivery, it was necessary to select anti-
bodies recognizing natural surface receptor CD205 by 
flow cytometry on chicken splenocytes and blood cells. 
Flow cytometry data were gated to exclude cell debris 
according to the cell granularity and size (SSC/FSC 
parameters). CD205 was expressed at very low levels on 
T cell subsets of leukocytes  (CD4+, TCRγδ+, and  CD8a+) 
as well as splenocytes. As shown in Figures  2B  and C, 
higher expression levels of CD205 were seen on  KUL01+ 
 CD11c+,  MHCII+ cells and  Bu1+ cells.
FITC-labeled cells incubated at 40  °C showed a sub-
stantial decrease of surface fluorescence intensity after 
1 and 2  h of incubation, while the cells left incubated 
at 4  °C showed similar fluorescence to the initial analy-
sis. MFI was reduced reaching 36.4% after 1 h and 26.8% 
after 2 h of incubation at 40 °C (Figure 2D). This indicates 
that the biot-anti-CD205-SA-FITC complex was internal-
ized into cells and entered the low pH milieu of the cell 
endocytic apparatus as FITC dye is pH-sensitive [34].
In vitro antigen restimulation
In order to verify the changed expression of the three 
major cytokines (IL-2, IL-12 and IFNγ), the in vitro res-
timulation of PBMC was performed. The levels of three 
cytokines detected in PBMC culture supernatants (Il-
2, IL-12 and IFNγ) were significantly increased in the 
immunized groups that were restimulated with v-src 
antigen. On the contrary, the amount of IL-10 was at the 
same level as in PBMC restimulated with v-src or con-
trol antigen or in the group without restimulation respec-
tively (Figure 3).
RSV‑induced tumor growth in the high (CB, CB.RI) and low 
(CC, CC.RI) responder chicken lines
As expected, the general pattern of the response to 
RSV challenge represented regression of relatively 
small tumors (≤2  g) in the CB and CB.RI lines, while 
progressive growth of tumors was observed in the CC 
and CC.RI lines even when challenged with a fivefold 
lower dose of RSV (Figure  4). The difference in the 
mean tumor weight 28 dpc between the regressor lines 
CB and CB.RI and progressor lines CC and CC.RI was 
highly significant (data not shown). However, on the 
contrary to expectations, we observed an exacerbat-
ing effect of immunization in the CB.RI (p < 0.01) and 
CC (p  <  0.05) chickens (Figure  4). However, a poten-
tial protective effect of immunization can be seen in 
the CB and CC.RI lines, but these differences were not 
significant. Interestingly, the adverse effect of vaccina-
tion correlates with the B-G4 allel presented in both 
CB.R1 and CC chickens. However, a protective effect 
was seen in the CB (regressors) chicks with MHC-B 
haplotype composed of its canonical partners the 
B-F12 and B-G12, and also in the CC.R1 (progressors) 
chicks with the B-G12 allele present in the recombi-
nant haplotype together with the B-F4—responsible for 
generally progressor phenotype (for composition of the 
MHC-B haplotypes see “Materials and methods”, and 
“Discussion”).
Comparison of the cytokine profiles in RSV‑challenged 
chickens of different congenic lines
Expression of twenty genes (see Additional file 4) active 
in chicken blood cells that can influence the process of 
immune response and consequently the tumor growth 
were tested. To compare the kinetics of the cytokine 
profiles in RSV-challenged chickens, we pooled CB and 
CB.RI lines and CC and CC.RI lines into the groups 
of regressors and progressors, respectively. The mul-
tidimensional information on cytokine gene expres-
sion profiles was transformed into a 2-dimensional plot 
using PCA. Classification of the tested samples based 
on PCA results was confirmed by discriminant analysis, 
in which a score of 100% was reached for the confusion 
matrix. Based on the multidimensional gene expression 
profile, the samples of all experimental chicken groups 
were classified into three clusters (Figure 5) at each sam-
pling time. In the group of regressors, the most promi-
nent difference in multidimensional cytokine expression 
between the immunized and non-immunized groups 
was detected 14  dpc, while in the group of progressors 
the most prominent difference was seen 28  dpc. In the 
non-immunized groups (all times) of regressors there 
were significant similarities of clusters in comparison to 
immunized regressor groups. Interestingly, the multidi-
mensional expression profiles in groups at time of chal-
lenge and 28 dpc (both non-immunized and immunized) 
were similar by F1 main component.
When comparing single cytokine expression profiles 
between progressor and regressor immunized and non-
immunized groups, several significant differences were 
found (see Additional file 5). A significant up-regulation 
of IL-2, IL-12, IL-15 and IL-18 expression was detected 
in immunized chickens of both regressor and progres-
sor groups. Of these cytokines, IL-2 and IL-12 expres-
sion was most up-regulated 14 dpc, while IL-15 and 
IL-18 were most up-regulated 28  dpc (Figure  6; IL-12, 
IL-18). On the contrary, IL-10 expression was signifi-
cantly down-regulated 14  dpc in all immunized groups 
of progressor chickens. Interestingly, we detected signifi-
cant up-regulation of IL-17 in the group of immunized 




Figure 2 Specific binding of anti-chCD205 and internalization of antigen delivery complex. A The recombinant parts of chicken CD205 
receptor used for monoclonal antibody preparation and the monoclonal antibody characterization. The CD205B and CD205F proteins were purified 
from inclusion bodies on DEAE Sepharose and separated on Tris-Tricine polyacrylamide gel stained by Coomassie blue (left). Monoclonal mouse 
anti-CD205 antibodies were analyzed using Western blots. Results of two representative detections of monoclonal anti-CD205 specific for CD205B 
or CD205F are shown. B CD205 expression on leukocytes. Splenocytes and peripheral leukocytes were stained with anti-chicken CD205 antibody 
and antibodies recognizing each of the indicated antigens. Histograms represent the CD205 fluorescence for cells gated for positive expression of 
the markers indicated at the left. The results of one representative of three experiments are shown. C Median fluorescence intensity (MFI) of CD205 
stained cells and standard deviation. D Internalization of streptavidin-CD205-FITC complex by chicken primary splenocytes one (left) and two (right) 
hours of incubation in different temperatures. Dotted line plot non-labelled cells (biot—control IgG); Black line plot—FITC labelled cells incubated 
in 4 °C; Gray line plot—FITC labelled cells incubated in 40 °C.
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progressors and significant up-regulation of MIF and 
XCL1 in both groups of progressors 14 dpc. Surprisingly, 
down-regulation of LITAF, a putative chicken analog 
of TNFα, and up-regulation of iNOS were observed 
especially in the progressor group of immunized chick-
ens that developed large tumors.
The cytokine pattern correlates with the RSV‑induced 
tumor status (regression/progression)
The PCA method and discrimination analysis were used 
for classification and discrimination of multimarker gene 
cytokine expression profiles of experimental chickens. 
Individual samples were distributed based on the tumor 
weight.
In the regressor lines, samples taken from chickens 
with small or large tumors formed distinct compact sets 
with significantly different expression cytokine profiles 
(Figure  7A). Analyses of progressor lines also showed 
significantly different expression profiles (Figure  7B). 
Among the set of 20 tested genes, 14 genes exhibited 
altered expression (Additional file  5). Fourteen genes 
(IL-1, IL-2, MIF, IL-4, IL-12, IL-18, IL-15, TLR7, TRAF5, 
XCL1, IL-17, TGF-β, iNOS, IFNγ) were found within the 
progressor lines, whereas six genes (IL-15, IL-18, IL-8, 
TGF-β, TLR7, iNOS) were found in the regressor lines. 
For detailed significance of data relations, see Table  1. 
The remaining marker genes (IFNα, IL-22, IL-13) were 
excluded from the panel as their expression did not 
change in response to immunization.
Discussion
In this report, we used a new system of vaccination with 
antigen delivery into chicken APC. For the first time in 
the chicken, we verified the ability of fusion complexes 
of RSV antigens with SA to target specific biotinylated 
































































































































































































Figure 3 In vitro Ag restimulation. The v-src-specific interleukin (IL-12, IL-2, IFNγ, IL-10) responses were measured in chickens of the CB and CB.RI 
lines using the Bio-Plex system in the culture supernatants. Horizontal bars indicate the mean values. The results represent at least two independent 
experiments. Control (n = 5 + 5): non-restimulated control; SA-vsrc-10 (n = 5 + 5): samples restimulated with the mixture of tetramers SA-vsrcA 
and SA-vsrcB of immunized and non-immunized animals; SA-10 (n = 5 + 5): free SA restimulation control. Statistical significance determined by the 
Student’s t test: *p < 0.05; **p < 0.01; ***p < 0.001.
Figure 4 Comparison of tumor size between control and 
immunized groups of chickens. For statistical analysis, the non-
immunized (A) and immunized (B) chickens of all inbred lines (CB, 
CB.RI, CC and CC.RI) were considered. Chickens of the regressor 
lines CB, CB.R1 and the progressor lines CC, CC.R1 were challenged 
with 100 FFU and 20 FFU of the RSV-PR-C respectively (for details 
see “Materials and methods”). Each column represents an average 
tumor size in the group of eight chickens (total number 64 chickens). 
*p < 0.05 non-parametric test (Mann–Whitney); **p < 0.01 both para-
metric (t test) and non-parametric test (Mann–Whitney).
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Figure 5 Comparison of the kinetics of cytokine pattern in RSV challenged chickens of different congenic lines. Classification of 
individual responses by PCA and discriminant analysis in immunized and non-immunized groups of regressors (A) and progressors (B). Samples 
were classified into three groups by using PCA (XLSTAT software). The first group (blue spots) includes samples taken on the time of challenge, the 
second group (green spots) includes samples obtained 14 days after challenge and the third group (brown spots) comprises samples obtained 
28 days after challenge. F1 and F2 represent the two main components.
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Figure 6 Single cytokine profiles of selected genes in progressor and regressor groups of immunized and non-immunized chickens. 
The expression value after challenge was normalized to the basic value expression in the day of challenge. For more cytokines, see Additional file 5.
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monoclonal antibody against chicken dendritic cell endo-
cytic surface receptor CD205 (Ly75) and used it in the 
described antigen delivery system.
Using the newly prepared monoclonal anti chicken 
CD205 antibody, we observed chCD205 expression in 
different subsets of chicken leucocytes, mainly in antigen 
presenting cells as described by Vu Manh et al. [35]. Our 
observations were recently confirmed by Stainess et  al. 
[4] who also found that CD205 expression was the high-
est in those chicken cells associated with antigen capture 
and presentation. We showed that the complex SA-RSV 
antigens-antibody was delivered specifically to the surface 
Figure 7 Analysis of correlation of cytokine pattern with RSV-induced tumor status by real-time PCR. Chickens were arbitrarily divided 
into two groups: small tumors—which stands for tumors up to 5 g (including completely regressed tumors) in the regressor lines CB and CB.R1 and 
for tumors up to 20 g in the progressor lines CC and CC.R1; large tumors—which stands for tumors above the weight 5 g in the CB and CB.R1 and 
above 20 g in the CC and CC.R1. A Classification of regressors individual responses by linear discriminant analysis. B Classification of progressors 
individual responses by linear discriminant analysis.
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CD205 receptor and subsequently internalized. As pH 
in endosomes/lysosomes is between 4.5 and 5.5 [36], the 
FITC fluorescence signal was expected to decrease after 
receptor endocytosis and transfer of the complex into 
the cell endosome apparatus. This was confirmed by our 
internalization experiments where we showed decreased 
fluorescence signals after incubation of FITC-CD205-
labeled chicken splenocytes at different temperatures.
In mammals, anti-CD205 antibodies are internalized 
via coated vesicles and are delivered to endosomal com-
partments [6]. The cytosolic domain of CD205 medi-
ates efficient endocytosis and recycling through the late 
endosomes and MHCII-rich compartments [5]. In addi-
tion to its capacity to shuttle antigens from the extra-
cellular space into specialized MHCII-rich lysosomal 
compartments, CD205 is also able to introduce antigens 
to the MHCI processing machinery.
We used poly I:C as an adjuvant, which acts as dsRNA 
recognized by TLR3 and thus mimics viral infec-
tion [37]. It is indicated that poly I:C can inhibit RSV 
transformation of chicken embryo fibroblasts in  vitro 
[38], however, in our experiments we observed no such 
effect and, importantly, a rapid progression of tumors in 
susceptible lines CC and CC.R1 were not compromised 
at all. This distinction may be connected with e.g. in vivo 
use, different site of administration or a prolonged inter-
val between immunization and challenge.
Antigen presentation by a subset of APC via MHCI 
molecules [39] provides a basis for protein vaccines when 
appropriately delivered. In this case, the genetic make-up 
of recipients, namely the ability of particular class I mol-
ecules to bind relevant peptides, is of great importance 
for successful protection. In our experiments, regressors, 
but not progressors, mount an effective CTL reaction 
against RSV tumor cell targets [13]. It turned out that this 
situation clearly corresponds to the presence of immu-
nogenic peptide motifs within the RSV proteins that are 
stringently recognized by MHCI molecules (B-F12) of 
the regressor line, whereas only sparse relaxed motifs 
are available for MHCI molecules (B-F4) of the progres-
sor line [17, 40]. A protective effect of vaccination with a 
single v-src-derived peptide identified to act against RSV 
challenge was demonstrated in the regressor chickens 
[41]. Many more peptides predicted to bind class I mol-
ecules from different disease-resistant chicken lines than 
from susceptible lines were found including Marek’s dis-
ease virus (MDV), infectious bursal disease virus (IBDV) 
and avian influenza virus [42–45]. It has been shown 
that some peptides derived from IBDV can be used as 
effective vaccine in chickens harboring the dominantly 
expressed class I molecule of the B12 haplotype. How-
ever, only one predicted peptide used for vaccination 
provided effective protection against the IBDV challenge, 
whereas vaccination with another peptide failed. In fact, 
even more severe signs of disease were observed in this 
case [43]. Thus, the data presented both in our paper and 
in other experimental systems strongly suggest the deci-
sive role of the genetic make-up of recipients on the effi-
ciency and final outcome of vaccination.
After activation of different chicken DC populations by 
direct in vivo antigen targeting of their surface receptor, 
we assume, in the case of regressors, antigen-dependent 
activation of both  CD8+ cytotoxic T lymphocytes and 
effector  CD4+ T cells, as well as activation of innate 
immunity cells. Other cell types such as natural killer 
cells (NK) and macrophages may also play a role in the 
immune responses against RSV tumors. In the case of 
progressors we do not suppose activation of an effective 
CTL reaction against RSV.
In this experiment, the cytokine response analyses 
showed significant up-regulation of IL-12, IL-2, IL-15 and 
IL-18 in the progressors, which reflects an anti-tumor 
immunity in the rapidly growing tumors. In this context, 
Table 1 Significant differences in cytokine expression pro-
files between groups with small or large tumors of immu-
nized and non-immunized chickens at particular time 
points
For more detailed explanation, see Additional file 5.
+ At this time point, no large tumor was developed.
* p < 0.05; ** p < 0.01; *** p < 0.001.
Imm. Non‑imm. Imm. Non‑
imm.
CB, CB.RI CC, CC.RI
14 dpc + Il-10* 14 dpc – IFNγ*
Il-15** Il-2** –
TLR* Il-4** Il-4*
28 dpc Il-2** – Il-8** –
− Il-4* Il-12** Il-12***
Il-8** – – Il-17*
– Il-12* iNOS*** –
Il-15*** Il-15** XCL1* XCL1*
Il-18** – – MIF***
– iNOS*** LITAF** –
– XCL1** TRAF5** –
– MIF** 28 dpc Il-1* –
TGF-β** TGF-β * Il-4* Il-4*
TLR7*** TLR7*** – Il-12**
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we can assume that DC at later stages of differentiation 
may regulate the activity of NK cells through the release 
of IL-12, IL-15 and IL-18, as has been reported [46]. DC 
are known to induce the growth and function of NK cells 
and play a crucial role in naïve T-cell priming. NK cells 
can influence the capability of DC to promote Th1 polari-
zation, and the prevalence of IL-12, IL-2, IL-18, or IL-4 at 
inflammatory sites may differentially modulate the NK-cell 
interaction with DC [47]. Interestingly, we detected sig-
nificant up-regulation of IL-17 in the group of immunized 
progressors. This is in accordance with the hypothesis that 
Th17 cells facilitate chemoattraction of Th1 cells [48].
In mammals, Cooper et  al. [49] showed that IL-12-, 
IL-15- and IL-18-induced NK cells were memory-like cells 
and exhibited responses upon restimulation with cytokines 
(IL-2 and IL-15). DC rapidly stimulate NK cells through 
production of cytokines, such as IL-2, IL-12, IL-15 and 
IL-18. It has been reported that DC vaccination generates 
long-term cell-based resistance against tumor cells in an 
antigen-independent manner [49]. In the process of onco-
genesis, we observed intriguing down-regulation of LITAF 
mainly in the group of immunized progressors with large 
tumors. Simultaneously, we did not detect any significant 
increase in the expression of IFNγ mainly in the immu-
nized groups of progressors, which would indicate involve-
ment of NK cells in the tumor interactions.
In chickens, there are several C-type lectins that 
are similar to certain mammalian natural killer recep-
tor genes located in the close vicinity of or even within 
the MHC-B [50–54]. Other novel families of poten-
tial chicken Ig-like receptors were also discovered [55]. 
B-NK was found on several T-cell subsets and also 
on  CD3−CD8+ sorted splenocytes that were in  vitro 
expanded by IL-2 and on embryonic splenocytes, both 
of which resemble chicken NK cells [56]. Our findings 
of specifically activated cytokines known to act in the 
NK-cell pathway point to their importance in our experi-
mental system of MHC-B congenic lines of chickens, 
in addition to the previously described Th1 antitumor 
response. NK cell receptors could be considered as both 
activating and inhibitory and the balance of their effects 
determines the final character of the immune response. 
It is within the context of these subtle and diverse factors, 
that the data presented in this report must be considered. 
We performed in vitro restimulation of PBMC where we 
evaluated supernatant levels of three cytokines (IL-2, 
IL-12 and IFNγ). Unfortunately, the availability of specific 
antibodies against chicken cytokines is limited; other 
cytokines were not evaluated therefore. All cytokine lev-
els were significantly increased in the immunized groups 
restimulated with v-src antigen. This suggests that the 
direct delivery of the antigens via CD205 receptor may 
also induce the classical Th1 immune profile.
Interestingly, both congenic lines sharing the B-G4 
allele, CB.R1 (regressors) and CC (progressors), showed 
a rather adverse effect of vaccination (for the composi-
tion of the MHC-B haplotypes see the “Materials and 
methods”). The true function of the B-G genes—known 
as MHC-B class IV—is still elusive, namely with respect 
to their immunological functions [26]. The significant 
role of the B-G genes in the relative resistance to MDV-
induced lymphoma has also been described in another 
experimental system of MHC-B recombinant chickens 
[28]. Our results suggest that the genotype in the B-G 
genes (MHC—class IV) correlates to some extent in the 
response to the vaccination despite the general status 
of regressors or progressors governed primarily by the 
B-F (MHCI) genes. So far, we can only speculate what 
putative suppressive signal of the B-G4 molecule might 
influence the significant aggravating of the vaccination 
response in our model system.
We report in this study the first description of a novel 
system of vaccination of chickens based on a novel tool 
for antigen delivery into chicken DC. A novel anti-
chCD205 monoclonal antibody has been developed and 
the internalization of the antigen through this recep-
tor has been confirmed. Cytokine expression profile 
differences in RSV-challenged progressor and regres-
sor chicken lines have been described. Based on the 
increased expression of cytokines specific for activated 
DC (IL-12, IL-15 and IL-18) we have shown partial stim-
ulation of specific cell types involved in cell-mediated 
immunity, although the only significant effect of immu-
nization on the tumor size has been confirmed in IL-12. 
Further investigation is needed to elucidate the appar-
ently complex mechanism of the response to vaccination 
and to optimize the system of antigen delivery to avoid 
unwanted suppressive effects.
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